Equity Focus
Sylios Corp (OTCMKTS:UNGS) Stock to Watch
BY JEFF ADAMS / ON DECEMBER 3, 2014 AT 8:49 AM /
Sylios Corp(OTCMKTS:UNGS) has been moving in a bearish trend since start of the year ,2014, but the stock did saw a major bullish rally in the month of March , 2014 when it touched its high of $0.005 at a trading volume of around $48.12 million.
After March UNGS facing downward trend till now.
The share price saw it’s highest of $0.01 while its lowest was $0.00 in last one year. The stock maintains normal liquidity with average volume of 0.08 million shares per day.
Sylios Corp(OTCMKTS:UNGS) has been a dire choice for promoters. UNGS is out of news for long time, issued no PR statements and also not involved in stock pump campaigns.
Sylios Corp(OTCMKTS:UNGS) based in St. Petersburg, FL, is a holding corporation with operations engaged in the exploration and development of oil and natural gas properties, investments in equities and corporate debt and the development of products utilized for the medical and recreational marijuana industry.
Sylios Corp(OTCMKTS:UNGS) is pleased to announce that it has retained a Connecticut-based investment banking firm as its financial advisor and investment banker to assist in the identification and structuring of potential acquisition transactions.
Sylios is a holding corporation with operations engaged in the exploration and development of oil and natural gas properties, investments in equities and corporate debt and the development of products utilized for the medical and recreational marijuana industry. A key element of the Company’s long-term strategy is to be a leader in the medical and recreational marijuana space by entering into key licensing agreements targeting first tier products and the acquisition of companies with products showing the potential for exponential growth.
The newly engaged investment banking firm, with a specialty in Mergers & Acquisitions, is in discussions with a number of companies in the areas of specialty healthcare, medical marijuana, payment processing, vaporizer and electronic inhalers and other verticals to complement the Company’s path of growth through its subsidiary, The Greater Cannabis Company.
Wayne Anderson, President of Sylios Corp, noted, “We are excited to complete our first licensing agreement through our subsidiary The Greater Cannabis Company, and delighted to have the support of such outstanding financial advisors who truly understand our industry and what we are trying to accomplish. Sylios has identified half a dozen products and/or acquisition targets in the medical and recreational marijuana industry that would complement our business goals and path to profitability. We expect to update shareholders in the coming weeks on the progress of any discussions.”
The Company will launch its website for The Greater Cannabis Company the week of September29th. The Company website for its e-commerce store, GCC Superstore, will launch the second week of October 2014. The Company has entered into a reseller agreement with Atmos Rx for the sale of their cannabis related accessory products and is in discussions with two other premier manufacturers of accessory products. Upon the launch of GCC Superstore, the Company projects it will have 150+ SKUs (stock keeping units) within multiple categories.
Sylios Corp(OTCMKTS:UNGS) is a typical development stage company with $0.00million cash and total assets of $5.29million. The company has total liabilities of $2.85 million resulting in positive equity. UNGS trading in green and continues to trade in impressive volume, however does not seem to be moving anywhere close to its earlier position in the near future.
Considering the fundamentals its market capitalization of $239,960 is clearly understated.
Copyright © 2014 — Equities Focus. All Rights Reserved.
All of my posts are strictly my own opinion. Please do your own DD before making any investments and only risk what you can afford to lose
